1. Nair J, Ehimare U, Beitman B, Nair S, Lavin A. Clinical review: evidence-based diagnosis and treatment of ADHD in children. Missouri medicine 2006; 103(6): 617-21.
2. Rapport MD. Attention deficit disorder with hyperactivity. Behavior therapy with children and adolescents. A clinical approach 1987; 325-367.
3. Biederman J, Spencer T. Attention deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biological psychiatry 1999; 46(9): 1234-42.
4. Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, Volkow N, et al. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev 2007; 17(1): 39-59.
5. Gizer IR, Ficks C, and Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 2009; 126(1): 51–90.
6. Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ, Williams GV. Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology 2004; 174: 3-16.
7. Obollo MA, Montiel S. Attention and the executive function. Rev Neural 2006; 42(2): 3-7.
8. Matsumoto M, Hidaka K, Tada S, Tasaki Y, Yamaguchi T. Full length cDNA cloning and distribution of human dopamine D4 receptor. Brain res molecular brain res 1995; 29(1): 157-62.
9. Faraone SV, Perlis RH, Doyle AE. Molecular genetics of attentiondeficit/hyperactivity disorder. Biol Psychiatry 2005; 57(11): 1313-23.
10. Staller JA, Faraone SV. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder. Expert Rev Neurother 2007; 7(4): 351-362.
11. Forssberg H, Fernell E, Waters S. Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorder. Behav Brain Funct 2006; 2(1): 40.
12. Li D, Sham PC, Owen MJ. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Molecular Genet 2006; 15: 2276-84.
13. Asghari V, Sanyal S, Buchwaldt S. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 1995; 65(3): 1157-65.
14. Rohde LA, Halpern R. Recentadvences on attention deficit/hyperactivity disorder. Journal de Pediatria, 80 Suppl 2004; (80)2: 61-70.
15. Oak JN, Oldenhof J, Van Tol HH. The dopamine D(4) receptor: One decade of research. Eur J Pharmacol 2000; 405(1): 303-327.
16. Holmes J, Payton A, Barrett JH. A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mol Psychiatry 2000; 5(5): 523-530.
17. Tahir E, Yazgan Y, Cirakoglu B. Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mol Psychiatry 2000; 5(4): 396–404.
18. Roman T, Schmitz M, Polanczyk G. Attention-deficit hyperactivity disorder: A study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am J Med Genet 2001; 105(5): 471–78.
19. Castellanos FX, Lau E, Tayebi N, Lee P, Long RE, Giedd JN. Lack of an association between a dopamine-4 receptor polymorphism and attention- deficit/hyperactivity disorder: Genetic and brain morphometric analyses. Mol Psychiatry1998; 3(5): 431–34.
20. Marino C, Giorda R, Vanzin L, Molteni M, Lorusso M. L, Nobile M, et al. No evidence for association and linkage disequilibrium between dyslexia and markers of four dopamine-related genes. Eur Child Adolesc Psychiatry 2003; 12(4): 198–202.
21. Johansson S, Halleland H, Halmّy A, Jcobsen KK, Landaas ET, Dramsdahl M, ET AL. Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat but not with DRD4 or SLC6A3 VNTRs. Am J Med Genet B Neuropsychiatr Genet 2008;147B(8): 1470–75.
22. Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, Volkow N, et al. .Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev 2007; 17(1): 39-59.
23. Ji HS, Paik KC, Park WS, Lim MH. No association between the response to methylphenidate and DRD4 gene polymorphism in Korean attention deficit hyperactivity disorder: A case control study. ClinPsychopharmacolNeurosci 2013; 11(1): 13-7.
25. Guney E, Iseri E, Ergun SG, Percin EF, Ergun MA, Yalcin O, et al. The Correlation of Attention Deficit Hyperactivity Disorder withDRD4 Gene Polymorphism in Turkey. Int J Hum Genet 2013; 13(3): 145-52.
26. Turic D, Swanson J, Sonuga-Barke E. DRD4 and DAT1in ADHD: Functionalneurobiology to pharmacogenetics. PharmgenomicsPers Med 2010; 3: 61-78.
27. Bidwell LC, Willcutt EG, McQueen MB, DeFries JC, Olson RK, Smith SD, et al. A family based association study of DRD4, DAT1, and 5HTT and continuous traits of attention-deficit hyperactivity disorder. Behav Genet 2011; 41:165-174.
28. Grizenko N, Fortier ME, Zadorozny C, Thakur G, Schmitz N, Duval R, Joober R. Maternal stress during pregnancy, ADHD symptomatology in children and genotype: Gene-environment nteraction. J Can Acad Child Adolesc Psychiatry2012; 21(1): 9-15.
29. Tabatabaei S.M, Amiri Sh, Faghfouri S, Noorazar Gh, AbdollahiFakhim Sh, Fakhari A. DRD4 Gene Polymorphisms as a Risk Factor for Children with Attention Deficit Hyperactivity Disorder in Iranian Population. International Scholarly Research Notices. 2017; 2494537- 5
30. Qian Q, Wang Y, Zhou R, Yang L, Faraone SV .Familybasedand case-control association studies of DRD4 andDAT1 polymorphisms in Chinese attention deficithyperactivity disorder patients suggest long repeatscontribute to genetic risk for the disorder. Am J MedGenet B Neuropsychiatr Genet2004; 128B(1): 84–89.
31. Faraone SV, Biederman J, Weiffenbach B, Keith T, Chu MP, Weaver A, et al . Dopamine D4 gene 7-repeat allele andattention deficit hyperactivity disorder. Am J Psychiatry 1999;156(5): 768–770.
32. Holmes J, Payton A, Barrett JH, Hever T, Fitzpatrick H,Trumper AL, et al . A family-basedand case-control association study of the dopamine D4receptor gene and dopamine transporter gene in attentiondeficit hyperactivity disorder. Mol Psychiatry 2000; 5(5): 523–530.
33. Curran S, Mill J, Sham P, Rijsdijk F, Marusic K, Taylor E,Asherson P . QTL association analysis of theDRD4 exon 3 VNTR polymorphism in a populationsample of children screened with a parent rating scalefor ADHD symptoms. Am J Med Genet 2001;105(4): 387–393.
34. Brookes KJ, Xu X, Chen CK, Huang YS, Wu YY, AshersonP .No evidence for the association of DRD4 withADHD in a Taiwanese population within-family study.BMC Med Genet 2005; 6: 31.
35. Kim YS, Leventhal BL, Kim SJ, Kim BN, Cheon KA, YooHJ, et al. Family-basedassociation study of DAT1 and DRD4 polymorphismin Korean children with ADHD. NeurosciLett 2005; 390(3):176–181.
36. Leung PW, Lee CC, Hung SF, Ho TP, Tang CP, Kwong SL, et al. Dopaminereceptor D4 (DRD4) gene in Han Chinese children withattention deficit/hyperactivity disorder (ADHD): Increased prevalence of the 2-repeat allele. Am J MedGenet (Neuropsychiatry Genet) 2005; 133(1): 54-56.